Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiro Katayama

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Metabolism: Clinical and Experimental|January 14, 2003
Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cellsToshiyuki Matsunaga, Takanori Nakajima, Takashi Miyazaki, et al.
Journal of Hypertension|May 16, 2013
Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetesYuichi Noguchi, Kei Asayama, Jan A Staessen, et al.
Diabetology International|January 4, 2019
Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyYoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, et al.
Diabetology International|January 4, 2019
Erratum to: Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyYoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, et al.
Diabetes Care|May 28, 2005
Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications StudyHirohito Sone, Sachiko Mizuno, Hitomi Fujii, et al.
Diabetes Research and Clinical Practice|June 7, 2005
Efficacy of glimepiride in Japanese type 2 diabetic subjectsKouichi Inukai, Masaki Watanabe, Youhei Nakashima, et al.
Biochimica Et Biophysica Acta|August 1, 2009
A possible role of lysophospholipids produced by calcium-independent phospholipase A(2) in membrane-raft budding and fissionTakanari Nakano, Ikuo Inoue, Rina Shinozaki, et al.
Journal of Atherosclerosis and Thrombosis|August 13, 2009
Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS)Hirohito Sone, Sachiko Tanaka, Satoshi Iimuro, et al.
Journal of Hypertension|June 13, 2015
Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysisHiromi Rakugi, Toshio Ogihara, Takao Saruta, et al.
Obesity (Silver Spring, Md.)|November 22, 2008
Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetesHirohito Sone, Sachiko Tanaka, Satoshi Iimuro, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Metabolism: Clinical and Experimental|January 14, 2003
Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cellsToshiyuki Matsunaga, Takanori Nakajima, Takashi Miyazaki, et al.
Journal of Hypertension|May 16, 2013
Predictive power of home blood pressure and clinic blood pressure in hypertensive patients with impaired glucose metabolism and diabetesYuichi Noguchi, Kei Asayama, Jan A Staessen, et al.
Diabetology International|January 4, 2019
Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyYoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, et al.
Diabetology International|January 4, 2019
Erratum to: Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic studyYoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, et al.
Diabetes Care|May 28, 2005
Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications StudyHirohito Sone, Sachiko Mizuno, Hitomi Fujii, et al.
Diabetes Research and Clinical Practice|June 7, 2005
Efficacy of glimepiride in Japanese type 2 diabetic subjectsKouichi Inukai, Masaki Watanabe, Youhei Nakashima, et al.
Biochimica Et Biophysica Acta|August 1, 2009
A possible role of lysophospholipids produced by calcium-independent phospholipase A(2) in membrane-raft budding and fissionTakanari Nakano, Ikuo Inoue, Rina Shinozaki, et al.
Journal of Atherosclerosis and Thrombosis|August 13, 2009
Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS)Hirohito Sone, Sachiko Tanaka, Satoshi Iimuro, et al.
Journal of Hypertension|June 13, 2015
Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysisHiromi Rakugi, Toshio Ogihara, Takao Saruta, et al.
Obesity (Silver Spring, Md.)|November 22, 2008
Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetesHirohito Sone, Sachiko Tanaka, Satoshi Iimuro, et al.
Pageof 13